NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Accounts Payables (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Accounts Payables came in at $799000.0 in Q4 2025, down 31.12% year-over-year from $1.2 million in Q4 2024, and down 26.9% quarter-over-quarter from $1.1 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Accounts Payables (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Accounts Payables across 6 years of filings, most recently posting $799000.0 for Q4 2025.

  • In Q4 2025, Accounts Payables fell 31.12% year-over-year to $799000.0; the TTM figure through Dec 2025 stood at $799000.0 (down 31.12% YoY), while the FY2025 annual figure was $799000.0, down 31.12% from the prior year.
  • Accounts Payables came in at $799000.0 for Q4 2025 at NeuroSense Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.4 million in Q1 2024 to a low of $39000.0 in Q4 2021.
  • Average Accounts Payables over 5 years is $882333.3, with a median of $913000.0 recorded in 2023.
  • Year-over-year, Accounts Payables soared 1176.92% in 2022 and sank 31.12% in 2025.
  • Over 5 years, Accounts Payables stood at $39000.0 in 2021, then soared by 1176.92% to $498000.0 in 2022, then soared by 192.97% to $1.5 million in 2023, then decreased by 20.49% to $1.2 million in 2024, then tumbled by 31.12% to $799000.0 in 2025.
  • Per Business Quant data, the three most recent Accounts Payables figures were $799000.0 in Q4 2025, $1.1 million in Q2 2025, and $1.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 1.16 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 167.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 1.52 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 25.08 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 799,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 799,000.00
Jun 30, 2025 1.09 Mn
Dec 31, 2024 1.16 Mn
Sep 30, 2024 1.39 Mn
Jun 30, 2024 1.48 Mn
Mar 31, 2024 2.38 Mn
Dec 31, 2023 1.46 Mn
Sep 30, 2023 913,000.00
Jun 30, 2023 1.09 Mn
Mar 31, 2023 419,000.00
Dec 31, 2022 498,000.00
Sep 30, 2022 206,000.00
Jun 30, 2022 120,000.00
Mar 31, 2022 180,000.00
Dec 31, 2021 39,000.00
Dec 31, 2020 55,000.00
API Access

NeuroSense Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NRSN&period=max&api_key=YOUR_API_KEY